Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2021 call → NOWe need answer YES/NO. Need analyze transcript. Question: does management explain where company's business is going by narrating what counterparties are themselves doing and scaling? Need identify if substantial part forward account consists of reporting on growth/expansion/ramp/adoption/program build-out of specific customers/partners/payers/operators/programs company already supplies/serves, such that company's coming volume presented as consequence of those parties' trajectories rather than company's selling effort. Let's parse transcript. Management discusses base business recovery, COVID testing, PAMA, M&A, health plan business with UnitedHealthcare and Anthem, Aetna renewal, Primark Delaware. Also back-to-school programs with partners CIC Health, Ginkgo Bioworks, Broad Institute. Need see if they narrate counterparties' own trajectories as driver. They mention "We continue to grow our health plan business and made progress in the quarter with value based programs with UnitedHealthcare and Anthem. Our volumes of these health plans are growing faster than the company average." That's about their own volumes, not counterparties' scaling. They mention Aetna renewal, Primark Delaware. They mention back-to-school: "We have engaged with businesses in the travel and [education] sectors in the quarter and working with partners to support a safe return of students to the classroom. We're also collaborating with CIC Health, Gingo Bioworks, Betel Memorial Institute to make testing easy, fast and affordable for school systems and other group settings across the country." This is about partnerships, but not necessarily narrating counterparties' own expansion. Later in Q&A, Steve discusses back-to-school: "we've been working with the different partners with two programs that are funded with the funding for testing. One is the 600 million program for return to school programs where we have partners to help us with that and school systems throughout the United States could apply for that money and get money to reimburse whatever program come up. And then there's a larger program to about $10 billion. But as you can understand, I mean, every school system throughout the United States is going to have its own plan. And so they're going to start ramping up soon than into the month of August and in September.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.